The Food and Drug Administration (FDA)’s Committee on Compounded Drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances that can be made by pharmacies, despite concerns raised over the lack of demonstrated benefits. FDA’s Pharmacy Compounding Advisory Committee (PCAC) heard public comments and viewed presentations from agency staff regarding the peptides BPC-157, KPV, TB-500, and MOTS-C. These peptides…
Please follow and like us:
